A detailed history of Moody National Bank Trust Division transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Moody National Bank Trust Division holds 60,370 shares of BCRX stock, worth $452,171. This represents 0.05% of its overall portfolio holdings.

Number of Shares
60,370
Previous 52,046 15.99%
Holding current value
$452,171
Previous $321,000 42.68%
% of portfolio
0.05%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$6.41 - $8.69 $53,356 - $72,335
8,324 Added 15.99%
60,370 $458,000
Q3 2023

Oct 12, 2023

BUY
$6.71 - $7.92 $64,181 - $75,754
9,565 Added 22.52%
52,046 $368,000
Q2 2023

Jul 07, 2023

BUY
$6.96 - $8.81 $34,055 - $43,107
4,893 Added 13.02%
42,481 $299,000
Q1 2023

Apr 19, 2023

BUY
$7.94 - $11.84 $94,223 - $140,505
11,867 Added 46.14%
37,588 $313,000
Q4 2022

Jan 11, 2023

BUY
$10.5 - $14.2 $3,255 - $4,402
310 Added 1.22%
25,721 $295,000
Q3 2022

Oct 05, 2022

BUY
$10.79 - $14.81 $274,184 - $376,336
25,411 New
25,411 $320,000
Q2 2019

Jul 22, 2019

SELL
$2.91 - $9.15 $1,940 - $6,103
-667 Closed
0 $0
Q1 2019

Apr 11, 2019

BUY
$7.38 - $9.72 $4,922 - $6,483
667 New
667 $5,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.